DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,536,901 | -23.4% | 2,403,672 | -3.8% | 0.83% | -36.2% |
Q2 2023 | $28,124,010 | +4.6% | 2,499,912 | +7.1% | 1.30% | +17.8% |
Q1 2023 | $26,894,972 | -13.5% | 2,334,633 | -13.0% | 1.10% | -15.4% |
Q4 2022 | $31,109,878 | -23.1% | 2,684,200 | -15.7% | 1.31% | -29.5% |
Q3 2022 | $40,439,000 | +68.2% | 3,184,200 | -9.0% | 1.85% | +17.1% |
Q2 2022 | $24,045,000 | -28.7% | 3,500,000 | 0.0% | 1.58% | -26.9% |
Q1 2022 | $33,740,000 | +23.8% | 3,500,000 | +52.7% | 2.16% | +12.5% |
Q4 2021 | $27,255,000 | – | 2,292,250 | – | 1.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |